Wire · opportunities
FDA Clears Beckman Coulter Assay to Differentiate Infections in 15 Minutes
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
The FDA cleared Beckman Coulter's Access MeMed BV assay, a rapid blood test that differentiates bacterial from viral infections within 15 minutes using existing hospital immunoassay analyzers. This assay aims to reduce unnecessary antibiotic use and healthcare costs by delivering faster, more accurate diagnostic information to clinicians.
This Wire brief sits within Fusion42's coverage of Medtech, and 6 sources have reported it between 3 Nov 2026 and 4 Nov 2026.
◆ ◆ The Wire takeaway
You can now offer a faster way for hospitals to cut antibiotic use and costs with this new test that fits existing machines. That speed creates a new window to improve patient treatment decisions before conventional results arrive.
◆ Coverage
6 sources · first reported 3 Nov 2026 · latest 4 Nov 2026
◆ Related on Wire
◆ Topics